Which patient population would most benefit from inhaled insulin (Afrezza)?

Afrezza has the fastest onset of action and peak and shortest duration of action of any of the “ultra-rapid” prandial insulins. Its peak effect is 45 minutes vs 2 hours for the fastest injected insulin. Its duration of action is 2-3 hours vs 5-8 hours for injected mealtime insulins. A recent study showed that people on an Afrezza/degludec combo achieved A1c’s that were as good as in a comparison group of people on the automated pumps. This is impressive. Also, the meal tolerance glucoses were lo...